The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World Practice.

Oncologist · 2023 · PMC10485290 · PMID 37014098

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Across all the included countries, the comparison of the 2016-2018 and 2019-2020 periods showed a trend toward decreasing use of ADT ± first-generation antiandrogens with a simultaneous increase in the use of ADT intensification therapy.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.